Advertisement
Screener

INMED PHARMACEUTICALS INC. (INM) Increase (Decrease) in Other Current Assets

2.8 / 5 stars · 68/120 Roast Me

INMED PHARMACEUTICALS INC. Increase (Decrease) in Other Current Assets

INMED PHARMACEUTICALS INC. (INM) reported Increase (Decrease) in Other Current Assets of $337.05 thousand for the 6-month period ending 2025-12-31, per its 10-Q filed 2026-02-11.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2026-02-11

  • INMED PHARMACEUTICALS INC. increase (decrease) in other current assets for the quarter ending 2025-12-31 was $467.04K, a 5.67% decline year-over-year.
  • INMED PHARMACEUTICALS INC. increase (decrease) in other current assets for the quarter ending 2025-09-30 was -$129.99K.
  • INMED PHARMACEUTICALS INC. increase (decrease) in other current assets for the quarter ending 2024-12-31 was $495.10K.
  • INMED PHARMACEUTICALS INC. increase (decrease) in other current assets for the quarter ending 2024-09-30 was -$328.87K.
Period endIncrease (Decrease) in Other Current Assets 3 monthIncrease (Decrease) in Other Current Assets 6 month
2025-12-31$467.04K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-11
$337.05K
10-Q · filed 2026-02-11
2025-09-30-$129.99K
10-Q · filed 2025-11-06
2024-12-31$495.10K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-11
$166.24K
10-Q · filed 2026-02-11
2024-09-30-$328.87K
10-Q · filed 2025-11-06

Similar stocks

Stock NameCountryMarket CapPE Ratio
Apimeds Pharmaceuticals US, Inc. (APUS)United States$0.008B
Ensysce Biosciences, Inc. (ENSC)United States$0.008B-0.37
CNS Pharmaceuticals, Inc. (CNSP)United States$0.007B
EXICURE, INC. (XCUR)United States$0.008B-1.54
Acurx Pharmaceuticals, Inc. (ACXP)United States$0.007B-0.97
SOLIGENIX, INC. (SNGX)United States$0.008B
Imunon, Inc. (IMNN)United States$0.008B-0.56
SYNLOGIC, INC. (SYBX)United States$0.007B
Bolt Biotherapeutics, Inc. (BOLT)United States$0.007B-0.26
Enveric Biosciences, Inc. (ENVB)United States$0.007B-0.63